Pediatric antiphospholipid syndrome

Area of Science:

• Autoimmune diseases
• Pediatric rheumatology
• Vascular medicine

Background:

• Antiphospholipid syndrome (APS) is a multisystem autoimmune disorder.
• It is defined by vascular thromboses and persistent antiphospholipid antibodies.
• Limited data exists regarding pediatric and neonatal APS.

Purpose of the Study:

• To review the existing literature on pediatric and neonatal APS.
• To identify critical gaps in knowledge concerning APS in young populations.
• To propose future research directions for pediatric APS.

Main Methods:

• Systematic literature review of studies on pediatric and neonatal APS.
• Analysis of data on incidence, prevalence, thrombosis risk, and treatment efficacy.
• Identification of research deficits and future study recommendations.

Main Results:

• Significant paucity of data on pediatric APS incidence and prevalence.
• Incomplete understanding of thrombosis risk factors in pediatric APS.
• Lack of established, evidence-based treatment guidelines for pediatric APS.

Conclusions:

• Urgent need for comprehensive research into pediatric APS.
• Further studies are required to define incidence, prevalence, and thrombosis risk.
• Development of effective, evidence-based treatment strategies for pediatric APS is crucial.